Filing Flows › cbdMD (YCBD) › Q3 FY26 › vs Q2 FY26
cbdMD (YCBD) Q3 FY26 vs Q2 FY26 (quarter over quarter)
cbdMD's revenue fell $86K (-2%) from $5.6M in Q2 FY26 to $5.6M in Q3 FY26.
cbdMD, Q3 FY26: revenue $5.6M (+21% year over year), operating margin -20.4%, net loss $1.1M, operating cash flow −$442K. The chart draws each line against Q2 FY26, the increases inside each band.
Every line
| Line | Q3 FY26 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $5.6M | $5.6M | −$86K | -2% |
| Net loss | $1.1M | $798K | $329K | +41% |
| Costs & expenses | $6.7M | $6.4M | $243K | +4% |
| Operating costs | $6.7M | $6.4M | $243K | +4% |
| Cost of revenue | $2.5M | $2.4M | $133K | +6% |
| Operating expenses | $4.2M | $4.1M | $110K | +3% |
| Operating cash sources | $1.1M | $798K | $329K | +41% |
| Depreciation & amortization | $259K | $252K | $7K | +3% |
| Working capital & other | $426K | −$176K | $602K | — |
| Cash used in operations | $442K | $722K | −$280K | -39% |
| Net loss absorbed | $1.1M | $798K | $329K | +41% |
Questions
How much did cbdMD's revenue grow quarter over quarter in Q3 FY26?
cbdMD's revenue fell $86K (-2%) from $5.6M in Q2 FY26 to $5.6M in Q3 FY26.